Recent General News

New Study Suggests Most Cancers are Unavoidable Irrespective of Life Style

(July 19, 2017)

Two thirds of cancers are unavoidable even if you live a healthy life, according to a study published by doctors from John Hopkins.  The research, published in the journal Science, indicates that the... Continue Reading


Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed

(April 21, 2017)

Small, phase one trial of a dendritic cell vaccine supports further study in larger trials A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy... Continue Reading


FDA Approves Bavencio as First Treatment for Merkel Cell Cancer

(March 31, 2017)

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma... Continue Reading


SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers

(March 23, 2017)

People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy... Continue Reading


Dealing with Distress

(March 17, 2017)

Why it’s important to acknowledge distress during cancer care and what to do about it By Teresa L. Deshields and Clorinda Walley The moment a patient is diagnosed with cancer, one symptom is likely to... Continue Reading


Xermelo-new option for controlling symptoms of Carcinoid Syndrome

(March 1, 2017)

The US Food and Drug Administration (FDA) today approved the oral therapy Xermelo (telotristat ethyl) to be used in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid... Continue Reading


Cancer Connect Launches On line Community for Patients with Neuroendocrine Tumors

(February 23, 2017)

Sun Valley ID & Austin TX— OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide... Continue Reading


It’s in the Genes: Genetic Testing Tutorial

(October 7, 2016)

Advances in genetic testing are offering women more information than ever before about their genetic makeup and are providing opportunities for empowered decision making related to a wide range of health... Continue Reading


Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101

(July 19, 2016)

Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... Continue Reading


FDA Designates Breakthrough Therapy Designation for Azedra in Pheochromocytoma and Paraganglioma

(August 12, 2015)

The U.S. Food and Drug Administration (FDA) has designated Azedra as a Breakthrough Therapy for the treatment of patients with iobenguane-avid metastatic or recurrent pheochromocytoma and paraganglioma.... Continue Reading


« Previous PageNext Page »